RIVARA, Mirko
 Distribuzione geografica
Continente #
EU - Europa 1.233
NA - Nord America 1.189
AS - Asia 492
AF - Africa 25
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 2.945
Nazione #
US - Stati Uniti d'America 1.170
CN - Cina 399
FI - Finlandia 253
SE - Svezia 239
IE - Irlanda 230
IT - Italia 201
UA - Ucraina 136
DE - Germania 90
SG - Singapore 56
GB - Regno Unito 35
TR - Turchia 31
CI - Costa d'Avorio 25
CA - Canada 19
CZ - Repubblica Ceca 15
BE - Belgio 12
FR - Francia 6
IN - India 6
PT - Portogallo 6
NL - Olanda 4
CL - Cile 3
RU - Federazione Russa 2
AL - Albania 1
AU - Australia 1
BR - Brasile 1
EU - Europa 1
LI - Liechtenstein 1
RO - Romania 1
RS - Serbia 1
Totale 2.945
Città #
Dublin 230
Chandler 226
Jacksonville 154
Beijing 99
Ann Arbor 97
Ashburn 85
Dearborn 67
Nanjing 61
Parma 54
Shanghai 47
Princeton 45
Milan 34
New York 32
Wilmington 32
Izmir 31
San Mateo 29
Singapore 29
Chicago 27
Abidjan 25
Boardman 19
Nanchang 17
Shenyang 17
Helsinki 16
Kunming 16
Guangzhou 15
Hefei 15
Jinan 15
Toronto 15
Bremen 14
Des Moines 14
Hebei 14
Los Angeles 14
Seattle 14
Brussels 12
Jiaxing 11
Brno 10
Woodbridge 10
Changsha 7
Piacenza 6
Reggio Emilia 6
Tianjin 6
Auburn Hills 5
Dallas 5
Falls Church 5
London 5
Norwalk 5
Abbiategrasso 4
Brescia 4
Chengdu 4
Düsseldorf 4
Roncadelle 4
Bologna 3
Buccinasco 3
Castelo Branco 3
Fremont 3
Grafing 3
Gualtieri 3
Haikou 3
Hangzhou 3
Modena 3
Ningbo 3
Novi di Modena 3
Pavia 3
Reggio Nell'emilia 3
St Andrews 3
Taiyuan 3
Taizhou 3
Trezzano Sul Naviglio 3
Vobarno 3
Wuhan 3
Zhengzhou 3
Baotou 2
Castelcovati 2
Cereda 2
Cesena 2
Chongqing 2
Frankfurt am Main 2
Fuzhou 2
Grezzago 2
Hertford 2
Lanzhou 2
Miami 2
Montepulciano 2
Naples 2
Oakville 2
Palermo 2
Terni 2
Torino 2
Xian 2
Alzate Brianza 1
Augusta 1
Brooklyn 1
Cambridge 1
Fairfield 1
Fiorano Modenese 1
Huizen 1
Jaipur 1
Massa 1
Munich 1
Niles 1
Totale 1.839
Nome #
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 93
QSAR study of 2-aminobenzimidazole derivatives as H3 antagonists 90
Cognition enhancing effect in rats of a selected histamine H3 receptor antagonist with good brain penetration 87
5-Benzylidene-hydantoins: synthesis and antiproliferative activity on A549 lung cancer cell line 85
3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line 83
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 82
A Short and Efficient Synthesis of the Selective H4 Receptor Agonist 4-Methylhistamine 80
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 79
Discovery of antitubercular 2,4-diphenyl-1H-imidazoles from chemical library repositioning and rational design 78
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 76
Novel Sodium Channel Antagonists in the Treatment of Neuropathic Pain 75
Drug repurposing approaches to fight Dengue virus infection and related diseases 75
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 73
Antioxidant and cytoprotective activity of indole derivatives related to melatonin 73
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 72
Chiral NMR discrimination of the diastereoisomeric salts of the H(3)-antagonist 2-[3-(1H-imidazol-4-ylmethyl)piperidin-1-yl]-1H-benzimidazole. 72
Synthesis, biological activity, QSAR and QSPR study of 2/aminobenzimidazole derivatives as potent H3-antagonists 72
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 72
Development of a GPCR model for SAR interpretation of classical and new H3 antagonists 72
Gene-Delivery Ability of New Hydrogenated and Partially Fluorinated Gemini bispyridinium Surfactants with Six Methylene Spacers 71
Advances in Design and Development of Sodium Channel Blockers. 70
2,4(5)-Diarylimidazoles: Synthesis and Biological Evaluation of a New Class of Sodium Channel Blockers against hNav1.2 68
Development and validation of a LC-MS method with electrospray ionization for the determination of the imidazole H(3) antagonist ROS203 in rat plasma. 66
Imidazole H3-antagonists: Relationship between Structure and Ex-vivo binding to Rat Brain H3-Receptors 66
NMR Analysis of a Series of Imidazobenzoxazines 63
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 63
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 61
Inhibition of NaV1.6 sodium channel currents by a novel series of 1,4-disubstituted-triazole derivatives obtained via copper-catalyzed click chemistry 59
Sodium Channel Blocking Activity and In-vivo Testing of New Phenyl-imidazole Derivatives. 59
COMPOSITIONS AND METHODS FOR BLOCKING SODIUM CHANNELS 58
2,4(5)-Diarylimidazoles as Inhibitors of hNaV1.2 Sodium Channels: Pharmacological Evaluationand Structure-Property Relationships 57
Anticonvulsant Activity of 2,4(5)-Diarylimidazoles in Mice and Rat Models 57
Biological evaluation of imidazobenzoxazines, imidazobenzoxazin-5-ones and imidazobenzoxazin-5-thiones as sodium channel blockers 55
Sodium channel blockers: a patent review (2010 - 2014) 53
Anticonvulsant Activity of 2,4(1H)-Diarylimidazoles in Mice and Rats Acute Seizure Models 52
Chemico-Physical Properties of Some 1,1′-Bis-alkyl-2,2′-hexane-1,6-diyl-bispyridinium Chlorides Hydrogenated and Partially Fluorinated for Gene Delivery 51
A Practical Synthesis of 2,4(5)-Diarylimidazoles from Simple Building Blocks 51
Synthesis and stability in biological media of 1H-imidazole-1-carboxylates of ROS203, an antagonist of the histamine H3 receptor. 51
Sodium Channel Blockers as Therapeutic Target for Treating Epilepsy: Recent Updates 50
Recent Advances in the Medicinal Chemistry of Sodium Channel Blockers and their Therapeutic Potential 47
In vivo Screening of Diarylimidazoles as Anticonvulsant Agents 47
Sodium channel blockers for neuropathic pain. 45
Microwave Assisted Efficient Synthesis of Imidazole-based Privileged Structure 41
NaV1.1 and NaV1.6 selective compounds reduce the behavior phenotype and epileptiform activity in a novel zebrafish model for Dravet syndrome 38
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 38
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 31
Subtype-selective small molecule inhibitors reveal a fundamental role for Nav1.7 in nociceptor electrogenesis, axonal conduction and presynaptic release 29
NEW ALKBH2 AND ALKBH5 INHIBITORS FOR TREATING GLIOBLASTOMA 13
IMIDAZOBENZOXAZIN-5-THIONE (MV1035) TO OVERCOME THE BLOOD-BRAIN BARRIER AND TARGET CNS DISEASES 6
New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma 4
Totale 3.009
Categoria #
all - tutte 11.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.769


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020517 0 90 35 7 46 52 92 16 55 70 11 43
2020/2021304 11 39 24 16 31 9 47 10 55 16 42 4
2021/2022229 3 2 5 18 14 7 29 26 21 17 17 70
2022/2023929 106 108 68 57 71 118 17 44 275 12 36 17
2023/2024411 22 32 11 14 43 84 38 29 19 21 35 63
2024/202583 64 19 0 0 0 0 0 0 0 0 0 0
Totale 3.009